Below are the most recent publications written about "Urinary Incontinence, Urge" by people in Profiles.
-
Moses RA, Broghammer JA, Breyer BN, Voelzke BB, Buckley JC, Erickson BA, Elliott S, Vanni AJ, Ramkumar N, Myers JB. Patient Risk Factors Associated with Reported Urinary Quality of Life Following Artificial Urinary Sphincter Placement: A Paired Pre and Postoperative Analysis. Urology. 2022 11; 169:226-232.
-
Theisen KM, Soubra A, Grove S, Vanni AJ, Erickson BA, Breyer BN, Myers JB, Voelzke B, Broghammer JA, Rourke KF, Alsikafi NF, Buckley JC, Peterson AC, Elliott SP. Association Between Ejaculatory Dysfunction and Post-Void Dribbling After Urethroplasty. Urology. 2021 07; 153:320-326.
-
Cotter KJ, Flynn KJ, Hahn AE, Voelzke BB, Myers JB, Smith TG, Elliott SP, Alsikafi NF, Breyer BN, Vanni AJ, Buckley JC, Zhao LC, Erickson BA. Prevalence of Post-Micturition Incontinence before and after Anterior Urethroplasty. J Urol. 2018 10; 200(4):843-847.
-
Siegel S, Noblett K, Mangel J, Bennett J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Zylstra S, Kan F, Berg KC. Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation. J Urol. 2018 01; 199(1):229-236.
-
Hampson LA, Elliott SP, Erickson BA, Vanni AJ, Myers JB, McClung C, Breyer BN, Smith TG, Hagedorn JC, Voelzke BB. Multicenter Analysis of Urinary Urgency and Urge Incontinence in Patients with Anterior Urethral Stricture Disease before and after Urethroplasty. J Urol. 2016 12; 196(6):1700-1705.
-
Siegel S, Noblett K, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Thiery E. Three-year Follow-up Results of a Prospective, Multicenter Study in Overactive Bladder Subjects Treated With Sacral Neuromodulation. Urology. 2016 Aug; 94:57-63.
-
Noblett K, Siegel S, Mangel J, Griebling TL, Sutherland SE, Bird ET, Comiter C, Culkin D, Bennett J, Zylstra S, Kan F, Berg KC. Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder. Neurourol Urodyn. 2016 Feb; 35(2):246-51.
-
Dubeau CE, Kraus SR, Griebling TL, Newman DK, Wyman JF, Johnson TM, Ouslander JG, Sun F, Gong J, Bavendam T. Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: a double-blind, placebo controlled trial. J Urol. 2014 02; 191(2):395-404.
-
DuBeau CE, Morrow JD, Kraus SR, Creanga D, Bavendam T. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials. Neurourol Urodyn. 2012 Nov; 31(8):1258-65.
-
Nijman RJ, Borgstein NG, Ellsworth P, Siggaard C. Long-term tolerability of tolterodine extended release in children 5-11 years of age: results from a 12-month, open-label study. Eur Urol. 2007 Nov; 52(5):1511-6.